Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Carousell becomes Singapore’s newest unicorn, Acorns names former Amazon executive as president, and Anghami partners with Amazon Prime
Online Marketplace Carousell Is Singapore’s Newest Unicorn
Online classifieds marketplace Carousell Pte became Singapore’s latest tech unicorn, raising funds at a $1.1 billion valuation as Southeast Asia’s e-commerce startups benefit from the pandemic and related lockdowns, according to Bloomberg.
The company got $100 million in a round led by South Korean private equity firm STIC Investments.
Carousell has weighed a U.S. listing via a merger with a blank-check company, people with knowledge of the matter said in June.
READAcorns Names Amazon Alum David Hijirida as President Ahead of IPO
Acorns Grow Inc. hired former Amazon.com Inc. executive David Hijirida as its president, as the savings and investing startup prepares to go public by merging with a blank-check company.
On May 27, Acorns entered into a definitive agreement to combine with Pioneer Merger Corp. (NASDAQ:PACX).
READAmazon Prime and Anghami Collaborate in Saudi Arabia and United Arab Emirates with Anghami Plus
Amazon and Anghami have today announced that Amazon Prime members in Saudi Arabia and the UAE can enjoy an exclusive six-months free offer on Anghami Plus, Anghami’s premium paid tier, with their Prime membership.
Prime members in Saudi Arabia and the UAE will receive a free six-month subscription to Anghami Plus, followed by 50% off the subscription fee for the next six months.
On March 3, Anghami entered into a definitive agreement to combine with Vistas Media (NASDAQ:VMAC).
READSAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced the completion of enrollment in its Phase 2a clinical trial evaluating the safety and efficacy of SAB-176 in a challenge study.
SAB-176 is a novel anti-influenza human immunotherapy designed to address the limitations of current treatments for moderate to severe seasonal influenza.
On June 22, SAB announced a planned merger with Big Cypress Acquisition Corp. (NASDAQ: BCYP).
READAt the SPAC of Dawn As a rough week in the market comes to a close, at least one de-SPAC has some cause to show off. Many fashion brands were among the hard hit in recent days and not simply for macro reasons. Luis Vuitton-owner LVMH (PA:MC) dropped this week after an earnings miss led...
Shepherd Ave Capital Acquisition Corp. (Nasdaq: SPHAU) is the latest SPAC to file to IPO, making 24 new registration statements that have filed since June 1, 2024. So far, only two of those 24 have gone public, but it does indicate an active August. In SPACLand at least, August is never slow. As for Shepherd...
At the SPAC of Dawn SPACs have now priced 20 IPOs seven months into 2024 with an eye on beating 2023’s total of 31 IPOs. With a little more than 5 months left in the year, it’s expected that SPACs should at least match that number by only needing to price roughly two IPOs per...
DT Cloud Star announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “DTSQU”, Thursday, July 25, 2024. The new SPAC aims to combine with an established business with long-term financial visibility, but has not limited itself to a particular industry or sector....
Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...